(Q47913363)

6 February 2018

editorial

0 references

title

Are we entering a new age for human vaccine adjuvants? (English)

1 reference

6 February 2018

author name string

Derek T O'Hagan

series ordinal

1

1 reference

6 February 2018

Christopher B Fox

series ordinal

2

1 reference

6 February 2018

publication date

6 May 2015

1 reference

6 February 2018

Expert Review of Vaccines

published in

1 reference

6 February 2018

volume

14

1 reference

6 February 2018

issue

7

1 reference

6 February 2018

page(s)

909-911

1 reference

6 February 2018

Synthesis and assembly of hepatitis B virus surface antigen particles in yeast

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1043273

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1043273

An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1043273

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1043273

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1043273

Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1043273

The roles of TLRs, RLRs and NLRs in pathogen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1043273

Rational design of small molecules as vaccine adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1043273

AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1043273

Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1043273

Vaccine adjuvant formulations: a pharmaceutical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1043273

10.1586/14760584.2015.1043273

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018